1. Guest, the two part 'News in Brief' for the week beginning 20th March 2023 is here.
    Dismiss Notice
  2. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Quality of life and persistence of COVID-19 symptoms 90 days after hospital discharge, 2022, Muñoz-Corona et al

Discussion in 'Long Covid research' started by Andy, Jul 13, 2022.

  1. Andy

    Andy Committee Member

    Hampshire, UK


    We aimed to describe the persistence of symptoms in coronavirus disease 2019 (COVID-19) and quality of life (QoL) among patients 90 days after their discharge from the hospital for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and to determine differences in QoL domains concerning the absence or presence of persistent symptoms.

    To measure QoL, we used a validated Spanish version of the 36-item Short Form Health Survey (SF-36).

    We included 141 patients. Ninety days after discharge, COVID-19 symptoms persisted in 107 patients (75.9%), with fatigue (55.3%) and joint pain (46.8%) being the most frequent. According to the SF-36, the role-physical score was the dimension with the lowest values (median score, 25; interquartile range, 0–75). Patients with joint pain, fatigue, and dyspnea had lower scores than patients without those symptoms, with 10 of the 13 evaluated SF-36 scales showing lower levels.

    Ninety days after hospital discharge from COVID-19 reference centers, most patients had persistent symptoms and had lower SF-36 scores than patients without symptoms. It is important to follow-up patients discharged from the hospital after SARS-CoV-2 infection, ideally through a post-COVID-19 health care clinic and rehabilitation program, to improve QoL in these patients.

    Open access, https://journals.sagepub.com/doi/10.1177/03000605221110492

Share This Page